loadpatents
name:-0.089515924453735
name:-0.014871120452881
name:-0.011348009109497
GREVEN; Simone Patent Filings

GREVEN; Simone

Patent Applications and Registrations

Patent applications and USPTO patent grants for GREVEN; Simone.The latest application filed is for "specific antibody-drug-conjugates (adcs) with ksp inhibitors and anti-cd123-antibodies".

Company Profile
9.15.51
  • GREVEN; Simone - Dormagen DE
  • Greven; Simone - DE
  • Greven; Simone - Wuppertal DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Specific Antibody-drug-conjugates (adcs) With Ksp Inhibitors And Anti-cd123-antibodies
App 20220267457 - LERCHEN; Hans-Georg ;   et al.
2022-08-25
Antibody Drug Conjugates (adcs) Having Enzymatically Cleavable Groups
App 20220016258 - LERCHEN; Hans-Georg ;   et al.
2022-01-20
Antibody drug conjugates (ADCS) and antibody prodrug conjugates (APDCS) with enzymatically cleavable groups
Grant 11,123,439 - Lerchen , et al. September 21, 2
2021-09-21
Binder/active Agent Conjugates Directed Against Cxcr5, Having Enzymatically Cleavable Linkers And Improved Activity Profile
App 20210275686 - JOHANNES; Sarah Anna Liesa ;   et al.
2021-09-09
Site Specific Homogeneous With Ksp Inhibitors
App 20210252161 - LERCHEN; Hans-Georg ;   et al.
2021-08-19
Specific Antibody-drug-conjugates (adcs) With Ksp Inhibitors And Anti-cd123-antibodies
App 20210230284 - LERCHEN; Hans-Georg ;   et al.
2021-07-29
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies
Grant 11,071,788 - Lerchen , et al. July 27, 2
2021-07-27
Atrial Natriuretic Peptide Engrafted Antibodies
App 20210139555 - MAYER-BARTSCHMID; Anke ;   et al.
2021-05-13
Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies
Grant 11,001,636 - Lerchen , et al. May 11, 2
2021-05-11
Site specific homogeneous with KSP inhibitors
Grant 10,973,923 - Lerchen , et al. April 13, 2
2021-04-13
Antibody Drug Conjugates (adcs) With Nampt Inhibitors
App 20200360531 - BOHNKE; Niels ;   et al.
2020-11-19
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies
Grant 10,744,205 - Lerchen , et al. A
2020-08-18
Antibody Drug Conjugates Of Kinesin Spindel Protein (ksp) Inhibitors With Antib7h3-antibodies
App 20200138970 - LERCHEN; Hans-Georg ;   et al.
2020-05-07
Antibody-drug conjugates (ADCs) of KSP inhibitors with aglycosylated anti-TWEAKR antibodies
Grant 10,485,880 - Lerchen , et al. Nov
2019-11-26
Prodrugs Of Cytotoxic Active Agents Having Enzymatically Cleavable Groups
App 20190351066 - LERCHEN; Hans-Georg ;   et al.
2019-11-21
Specific Antibody-drug-conjugates (adcs) With Ksp Inhibitors And Anti-cd123-antibodies
App 20190330357 - LERCHEN; Hans-Georg ;   et al.
2019-10-31
Antibody Drug Conjugates (adcs) Having Enzymatically Cleavable Groups
App 20190328897 - LERCHEN; Hans-Georg ;   et al.
2019-10-31
Site Specific Homogeneous With Ksp Inhibitors
App 20190262463 - LERCHEN; Hans-Georg ;   et al.
2019-08-29
Prodrugs Of Cytotoxic Active Agents Having Enzymatically Cleavable Groups
App 20190077752 - LERCHEN; Hans-Georg ;   et al.
2019-03-14
Antibody Drug Conjugates Of Kinesin Spindel Protein (ksp) Inhibitors With Anti-cd123-antibodies
App 20180318437 - LERCHEN; Hans-Georg ;   et al.
2018-11-08
Antibody Drug Conjugates Of Kinesin Spindel Protein (ksp) Inhibitors With Anti-tweakr-antibodies
App 20180318438 - LERCHEN; Hans-Georg ;   et al.
2018-11-08
Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
Grant 10,022,453 - Lerchen , et al. July 17, 2
2018-07-17
Antibody Drug Conjugates Of Kinesin Spindel Protein (ksp) Inhibitors With Anti-b7h3-antibodies
App 20180185510 - LERCHEN; Hans-Georg ;   et al.
2018-07-05
Antibody Drug Conjugates (adcs) And Antibody Prodrug Conjugates (apdcs) With Enzymatically Cleavable Groups
App 20180169256 - LERCHEN; Hans-Georg ;   et al.
2018-06-21
Antibody-drug Conjugates (adcs) Of Ksp Inhibitors With Aglycosylated Anti-tweakr Antibodies
App 20180015176 - LERCHEN; Hans-Georg ;   et al.
2018-01-18
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
Grant 9,777,063 - Freiberg , et al. October 3, 2
2017-10-03
Anti-c4.4a Antibodies And Uses Thereof
App 20170158775 - LINDEN; Lars ;   et al.
2017-06-08
Neutralizing prolactin receptor antibodies and their therapeutic use
Grant 9,649,374 - Otto , et al. May 16, 2
2017-05-16
Antibody Drug Conjugates (adcs) With Kinesin Spindel Protein (ksp)
App 20160346402 - LERCHEN; Hans-Georg ;   et al.
2016-12-01
Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use
App 20160319029 - FREIBERG; Christoph ;   et al.
2016-11-03
Anti-tweakr Antibodies And Uses Thereof
App 20160237160 - VOTSMEIER; Christian ;   et al.
2016-08-18
New Binder-drug Conjugates (adcs) And Use Thereof
App 20160193359 - LERCHEN; Hans-Georg ;   et al.
2016-07-07
Neutralizing prolactin receptor antibody Mat3 and its therapeutic use
Grant 9,353,186 - Freiberg , et al. May 31, 2
2016-05-31
Neutralizing prolactin receptor antibodies and their therapeutic use
Grant 9,241,989 - Otto , et al. January 26, 2
2016-01-26
Pdgfrbeta-fc Fusion Proteins And Uses Thereof
App 20160009776 - Linden; Lars ;   et al.
2016-01-14
NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME
App 20150246136 - LERCHEN; Hans-Georg ;   et al.
2015-09-03
Binder-drug conjugates (ADCs) and use thereof
Grant 8,992,932 - Lerchen , et al. March 31, 2
2015-03-31
Novel Binder-drug Conjugates (adcs) And Use Thereof
App 20150030618 - LERCHEN; Hans-Georg ;   et al.
2015-01-29
New Antibody Drug Conjugates (adcs) And The Use Thereof
App 20150023989 - Lerchen; Hans-Georg ;   et al.
2015-01-22
Anti-FGFR2 Antibodies and Uses Thereof
App 20140322220 - Harrenga; Axel ;   et al.
2014-10-30
Neutralizing Prolactin Receptor Antibody Mat3 And Its Therapeutic Use
App 20140141003 - Freiberg; Christoph ;   et al.
2014-05-22
Novel Binder-Drug Conjugates (ADCs) and Use of Same
App 20140127240 - Lerchen; Hans-Georg ;   et al.
2014-05-08
Binding Proteins To Inhibitors Of Coagulation Factors
App 20140050743 - Dittmer; Frank ;   et al.
2014-02-20
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130272968 - Otto; Christiane ;   et al.
2013-10-17
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130171147 - Otto; Christiane ;   et al.
2013-07-04
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130129739 - Ottto; Christiane ;   et al.
2013-05-23
New Binder-drug Conjugates (adcs) And Use Thereof
App 20130122024 - LERCHEN; Hans-Georg ;   et al.
2013-05-16
New binder-drug conjugates (ADCs) and use thereof
App 20130095123 - Lerchen; Hans-Georg ;   et al.
2013-04-18
New Binder-drug Conjugates (adcs) And Use Thereof
App 20130066055 - Lerchen; Hans-Georg ;   et al.
2013-03-14
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20130022606 - Otto; Christiane ;   et al.
2013-01-24
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20120321632 - Otto; Christiane ;   et al.
2012-12-20
Anti-c4.4a Antibodies And Uses Thereof
App 20120321619 - Linden; Lars ;   et al.
2012-12-20
Neutralizing Prolactin Receptor Antibodies And Their Therapeutic Use
App 20120315276 - Otto; Christiane ;   et al.
2012-12-13
Chimeric Kunitz Domains and their Use
App 20090170766 - Oehme; Felix ;   et al.
2009-07-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed